Skystar Bio-Pharmaceutical Company engages in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People’s Republic of China (‘China’ or the ‘PRC’). The company’s operations are carried out by its subsidiaries in China and Xi’an Tianxing Bio-Pharmaceutical Co., Limited (Xi’an Tianxing), a PRC joint stock company. Products The company has 4 major product lines, such as micro-organism products line that includes approximately 16 products; veterinary medicine line for poultry and livestock that includes approximately 145 products; feed additives line that includes approximately 16 products; and bio-pharmaceutical veterinary vaccine line that includes approximately 10 products. Customers As of December 31, 2013, the company had approximately 4,000 customers in 29 provinces in China, including 2,893 distributors and 1,122 direct customers. Of the 2,893 distributors, 360 are physical stores that have outer signage with the company’s logo and sell products from its 4 product lines that are known as ‘franchise distributors’. Suppliers The company’s suppliers include Xi’an Yanghua Chemical Co., Ltd.; Xi’an Fandike Chemical Technology Co., Ltd.; Xi’an Chenyue Trading Co.; Xi’an Lijun Baichuan Pharmaceutical Chemical Co., Ltd.; and Xi'an Wan Shou Bei Lu Longkui Chinese Medicine Store. Intellectual Property Skywing, Stardove, Tian Xing, Hao Shou Yi, and the Chinese characters that transliterate as ‘Jia Teng Jun’, ‘Jia Teng’, ‘Lan Yuan Kang’, ‘Bao Li Jian’, and ‘Bi Ke Ting’ are the company’s registered trademarks in the PRC. Government Approval and Regulation The Chinese Ministry of Agriculture has granted Xi’an Tianxing three government permits to produce various products, such as forage additive products, additive and mixed forage products, and veterinary medicine products. In addition, the Chinese Ministry of Agriculture has granted Xi’an Tianxing’s subsidiary, Xi’an Sikaida Bio-products Co., Ltd., the government permit to produce veterinary vaccine products. The Chinese Ministry of Agriculture has also granted the company’s subsidiary, Skystar Biotechnology (Jingzhou) Co., Limited, the government permit to produce veterinary medicine products. Research and Development The company launched various R&D projects on veterinary products formula adjustment, pet drug development, fermentation engineering design and development, Good Manufacturing Practice inspection trial production tests and lab tests. In 2013, the company spent $956,028 of its revenue on R&D. Competition Qilu Animal Health Production Co., Ltd. and China Animal Husbandry Industry Co. Ltd. are the company’s primary competitors in the sector of veterinary medicine products. Qilu Animal Health Production Co., Ltd.; China Animal Husbandry Industry Co. Ltd.; and Guangdong VTR Bio-Tech Co., Ltd are the company’s primary competitors in the sectors of micro-organism and feed additives products. Xinjiang Tecon Animal Husbandry Bio-technology Co., Ltd. and Inner Mongolia Jinyu Group Stock Company are its primary competitors in the sector of veterinary vaccine products. History Skystar Bio-Pharmaceutical Company was incorporated in Nevada in 1998.
No. 48 Keji Road, Gaoxin District
Phone: 86 29 8819 3188
|China Animal Husbandry Industry Co Ltd||CNY23.23 CNY||+0.58|
|Guangdong VTR Bio-Tech Co Ltd||CNY41.09 CNY||0.00|
|Inner Mongolia Jinyu Group Ltd||CNY60.30 CNY||+1.02|
|Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd||CNY21.33 CNY||+0.40|
|View Industry Companies|
Sponsored Financial Commentaries
To contact SKYSTAR BIO-PHARMACEUTICAL, please visit www.skystarbio-pharmaceutical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.